Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

NCT00666978 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 540

Last updated 2017-11-13

Study results available
· View outcomes & findings →

Summary

RATIONALE: A stop-smoking plan that includes health education counseling and bupropion may help African-American smokers stop smoking. It is not yet known whether health education counseling is more effective with or without bupropion in helping African Americans stop smoking.

PURPOSE: This clinical trial is studying health education counseling and bupropion to see how well they work compared with a placebo and health education counseling in helping African Americans smokers stop smoking.

Conditions

Interventions

BEHAVIORAL

smoking cessation intervention

DRUG

bupropion hydrochloride

GENETIC

gene expression analysis

GENETIC

polymerase chain reaction

OTHER

counseling intervention

OTHER

educational intervention

PROCEDURE

psychosocial assessment and care

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Lisa Sanderson Cox, PhD

    lead OTHER

Principal Investigators

  • Lisa S. Cox, PhD · University of Kansas

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00666978 on ClinicalTrials.gov